Biogen receives EC approval for QALSODY to treat rare genetic form of ALS
EC granted marketing authorisation under exceptional circumstances and maintained orphan designation for QALSODY (tofersen) for…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
EC approval
Kyowa Kirin gets EC approval for CRYSVITA (burosumab) to treat X-Linked hypophosphataemia in older…
It was previously approved for the treatment of XLH with radiographic evidence of bone disease in children one year of age and…